Albumin In Situ Hybridization Can Be Positive in Adenocarcinomas and Other Tumors From Diverse Sites

Aqsa Nasir, Heidi D. Lehrke, Taofic Mounajjed, Samar Said, Lizhi Zhang, Saba Yasir, Sejal M Shah, Vishal S Chandran, Thomas Christopher Smyrk, Roger K. Moreira, Jennifer M. Boland Froemming, Loren P. Herrera Hernandez, Tsung Teh Wu, Rondell P. Graham

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

OBJECTIVES: Albumin messenger RNA (mRNA) expression is a marker of hepatocellular differentiation. Most published data are from review of tissue microarrays, and albumin in situ hybridization (ISH) expression across several tumor types is incompletely characterized. METHODS: Sections from 221 tumors were evaluated for albumin mRNA. Immunohistochemistry was used to confirm diagnoses. Albumin ISH was performed according to manufacturer-provided instructions. Fifty-nine cases were evaluated with both commercial ISH assays. RESULTS: Albumin mRNA was detected in all hepatocellular carcinomas (HCCs) and 81% of intrahepatic cholangiocarcinomas. Lung (20%), gallbladder (39%), hepatoid pancreatic (n = 1 of 1) adenocarcinoma, breast invasive ductal carcinoma (18%), yolk sac tumor (25%), and acinar cell carcinoma (29%) showed expression. Both assays were concordant in 93% of cases. CONCLUSIONS: Albumin ISH was expressed in all HCCs studied. It was also positive in intrahepatic cholangiocarcinoma and patchy positive in gallbladder adenocarcinoma and a subset of other neoplasms, which can be a potential pitfall.

Original languageEnglish (US)
Pages (from-to)190-199
Number of pages10
JournalAmerican journal of clinical pathology
Volume152
Issue number2
DOIs
StatePublished - Jul 5 2019

Keywords

  • Albumin
  • Hepatocellular
  • Hepatocellular carcinoma
  • In situ hybridization
  • Intrahepatic cholangiocarcinoma
  • Liver

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Albumin In Situ Hybridization Can Be Positive in Adenocarcinomas and Other Tumors From Diverse Sites'. Together they form a unique fingerprint.

  • Cite this

    Nasir, A., Lehrke, H. D., Mounajjed, T., Said, S., Zhang, L., Yasir, S., Shah, S. M., Chandran, V. S., Smyrk, T. C., Moreira, R. K., Boland Froemming, J. M., Herrera Hernandez, L. P., Wu, T. T., & Graham, R. P. (2019). Albumin In Situ Hybridization Can Be Positive in Adenocarcinomas and Other Tumors From Diverse Sites. American journal of clinical pathology, 152(2), 190-199. https://doi.org/10.1093/ajcp/aqz032